IP Library › Assignment 067285/0965
Patent Assignment
Reel/Frame 067285/0965

Change of Name

Recorded: 2024-05-01 Pages: 17
Assignor
CALIDI BIOTHERAPEUTICS, INC.
Executed: 2024-01-30
Assignee
CALIDI BIOTHERAPEUTICS (NEVADA), INC.
4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (2)
Combination Immunotherapy Approach for Treatment of Cancer
Application: 17/689,643 →
Publication: US US20220241388A1
Combination Immunotherapy Approach for Treatment of Cancer
Application: 15/521,602 →
Publication: US US20170239338A1
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 24, 2017
From: SZALAY, ALADAR; MINEV, BORIS
To: STEMIMMUNE, INCORPORATED
Reel/Frame 042132/0484 →
Change of Name Jul 20, 2018
From: STEMIMMUNE, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 046844/0903 →
Merger Feb 20, 2020
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 051875/0738 →
Assignment of Assignor's Interest Mar 9, 2022
From: SZALAY, ALADAR; MINEV, BORIS
To: STEMIMMUNE, INCORPORATED
Reel/Frame 059214/0775 →
Merger Mar 9, 2022
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 059214/0829 →
Change of Name Mar 9, 2022
From: STEMIMMUNE, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 059357/0545 →